^
Association details:
Biomarker:No biomarker
Cancer:Kaposi Sarcoma
Drug:sirolimus (mTOR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
02/12/2021
Excerpt:
Kaposi Sarcoma: Subsequent systemic therapy options for relapsed/refractory therapy...Useful in certain circumstances...Sirolimus